# Neurexan - a Clinical Trial in Short-Term Insomnia Patients

> **NCT06278077** · PHASE2 · COMPLETED · sponsor: **Biologische Heilmittel Heel GmbH** · enrollment: 81 (actual)

## Conditions studied

- Insomnia
- Stress Reaction

## Interventions

- **DRUG:** Neurexan
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06278077
- **Lead sponsor:** Biologische Heilmittel Heel GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-09-06
- **Primary completion:** 2026-01-31
- **Final completion:** 2026-02-16
- **Target enrollment:** 81 (ACTUAL)
- **Last updated:** 2026-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06278077

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06278077, "Neurexan - a Clinical Trial in Short-Term Insomnia Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06278077. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*